Erste Asset Management GmbH Has $51.90 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• Erste Asset Management GmbH increased its stake in Intuitive Surgical by 6.5%, bringing its holdings to over 104,000 shares valued at approximately $51.9 million.
• Recent analyst reports suggest a consensus rating of "Moderate Buy" for Intuitive Surgical, with price targets varying from $550 to $595.
• Insider activity has seen significant selling, including Gary S. Guthart and Myriam Curet who sold thousands of shares, indicating potential shifts in investor sentiment.

Erste Asset Management GmbH raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 6.5% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 104,057 shares of the medical equipment provider's stock after buying an additional 6,381 shares during the period. Erste Asset Management GmbH's holdings in Intuitive Surgical were worth $51,898,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of ISRG. AlphaCore Capital LLC increased its stake in shares of Intuitive Surgical by 4.2% during the fourth quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock worth $235,000 after purchasing an additional 18 shares during the period. Second Line Capital LLC increased its stake in shares of Intuitive Surgical by 3.4% during the fourth quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock worth $302,000 after purchasing an additional 19 shares during the period. Colonial Trust Co SC increased its stake in shares of Intuitive Surgical by 8.8% during the fourth quarter. Colonial Trust Co SC now owns 246 shares of the medical equipment provider's stock worth $128,000 after purchasing an additional 20 shares during the period. Crown Wealth Group LLC increased its stake in shares of Intuitive Surgical by 4.8% during the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock worth $218,000 after purchasing an additional 20 shares during the period. Finally, FSM Wealth Advisors LLC increased its stake in shares of Intuitive Surgical by 3.8% during the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider's stock worth $270,000 after purchasing an additional 20 shares during the period. Institutional investors own 83.64% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on ISRG shares. Evercore ISI increased their target price on Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research note on Tuesday, July 8th. Piper Sandler reissued an "overweight" rating and issued a $595.00 price objective (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Erste Group Bank reissued a "hold" rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Royal Bank Of Canada reissued an "outperform" rating and issued a $615.00 price objective on shares of Intuitive Surgical in a report on Tuesday. Finally, Wall Street Zen raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Saturday, July 26th. Thirteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus target price of $595.95.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 2,800 shares of the firm's stock in a transaction on Monday, July 28th. The stock was sold at an average price of $495.24, for a total value of $1,386,672.00. Following the sale, the insider owned 18,520 shares of the company's stock, valued at approximately $9,171,844.80. This trade represents a 13.13% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president directly owned 907 shares in the company, valued at approximately $510,740.77. This represents a 19.23% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,839 shares of company stock valued at $7,896,972. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Price Performance

Intuitive Surgical stock traded up $6.28 during mid-day trading on Friday, reaching $476.16. 2,023,902 shares of the company were exchanged, compared to its average volume of 1,973,062. The company has a fifty day simple moving average of $504.42 and a 200-day simple moving average of $522.06. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The firm has a market cap of $170.69 billion, a PE ratio of 66.41, a PEG ratio of 4.92 and a beta of 1.59.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company's revenue was up 21.4% on a year-over-year basis. During the same quarter last year, the company earned $1.78 EPS. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.